Friday, Apr 19, 2024 | Last Update : 11:59 AM IST

tenofovir alafenamide

Gilead's three-drug HIV regimen wins European panel approval

Biktarvy is once-daily tablet combining emtricitabine, tenofovir alafenamide and integrase inhibitor bictegravir.

30 Apr 2018 9:57 AM

ADVERTISEMENT
ADVERTISEMENT